Summary BrainCells Inc. (BrainCells) is a bio-pharmaceutical company. It provides services for discovery and development of drugs for the treatment of various central nervous system diseases based on its novel neurogenic platform technology. The company also provides translation of the science of neurogenesis into clinical practice through its technology platform. The company's products include BCI-540 for the treatment of depression with anxiety, BCI-952 for depression, and BCI-632 for cognition and depression. BrainCells extends collaborations with select bio-pharmaceutical companies to leverage its technological platform. The company has signed an agreement with Proximagen Group to acquire sabcomeline, a clinical-stage muscarinic partial agonist that provides treatment of various psychiatric and neurologic disorders. BrainCells is headquartered in San Diego, California, the US. BrainCells Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year... Research Beam Model: Research Beam Product ID: 129422 250 USD New
BrainCells Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

BrainCells Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2014
  • Pages : 19
  • Publisher : GlobalData
 
 
 
Summary

BrainCells Inc. (BrainCells) is a bio-pharmaceutical company. It provides services for discovery and development of drugs for the treatment of various central nervous system diseases based on its novel neurogenic platform technology. The company also provides translation of the science of neurogenesis into clinical practice through its technology platform. The company's products include BCI-540 for the treatment of depression with anxiety, BCI-952 for depression, and BCI-632 for cognition and depression. BrainCells extends collaborations with select bio-pharmaceutical companies to leverage its technological platform. The company has signed an agreement with Proximagen Group to acquire sabcomeline, a clinical-stage muscarinic partial agonist that provides treatment of various psychiatric and neurologic disorders. BrainCells is headquartered in San Diego, California, the US.

BrainCells Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
BrainCells Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 6
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 8
BrainCells Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9
BrainCells Inc., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BrainCells Raises Additional US$2 Million In Venture Financing 10
BrainCells Secures US$0.99 Million In Venture Financing 11
BrainCells Secures US$50 Million In Series B Financing 12
Licensing Agreements 14
Proximagen Group Enters Into Licensing Agreement With BrainCells 14
BrainCells Inc. - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List Of Tables
List of Tables
BrainCells Inc., Pharmaceuticals & Healthcare, Key Facts 1
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
BrainCells Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 6
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
BrainCells Inc., Deals By Therapy Area, 2008 to YTD 2014 8
BrainCells Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9
BrainCells Raises Additional US$2 Million In Venture Financing 10
BrainCells Secures US$0.99 Million In Venture Financing 11
BrainCells Secures US$50 Million In Series B Financing 12
Proximagen Group Enters Into Licensing Agreement With BrainCells 14
BrainCells Inc., Key Competitors 16
BrainCells Inc., Key Employees 17
List Of Figures
List of Figures
BrainCells Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 1
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 1
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 1
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 1
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
BrainCells Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 6
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
BrainCells Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter